Biased and unbiased strategies to identify biologically active small molecules

被引:14
作者
Abet, Valentina [1 ]
Mariani, Angelica [1 ]
Truscott, Fiona R. [1 ]
Britton, Sebastien [2 ,3 ]
Rodriguez, Raphael [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France
[2] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
[3] Univ Toulouse 3, Univ Toulouse, Equipe Labellisee Ligue Canc, F-31077 Toulouse, France
关键词
Drug discovery; Dynamic combinatorial chemistry; In situ click chemistry; Fragment-based drug discovery; Diversity-oriented synthesis; DIVERSITY-ORIENTED SYNTHESIS; SITU CLICK CHEMISTRY; DYNAMIC COMBINATORIAL CHEMISTRY; DEPENDENT KINASE INHIBITOR; FRAGMENT-BASED DISCOVERY; HISTONE DEACETYLASE INHIBITORS; POTENT AURORA KINASE; CELL-BASED ASSAYS; DRUG DISCOVERY; IN-SITU;
D O I
10.1016/j.bmc.2014.04.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small molecules are central players in chemical biology studies. They promote the perturbation of cellular processes underlying diseases and enable the identification of biological targets that can be validated for therapeutic intervention. Small molecules have been shown to accurately tune a single function of pluripotent proteins in a reversible manner with exceptional temporal resolution. The identification of molecular probes and drugs remains a worthy challenge that can be addressed by the use of biased and unbiased strategies. Hypothesis-driven methodologies employs a known biological target to synthesize complementary hits while discovery-driven strategies offer the additional means of identifying previously unanticipated biological targets. This review article provides a general overview of recent synthetic frameworks that gave rise to an impressive arsenal of biologically active small molecules with unprecedented cellular mechanisms. (C) 2014 Published by Elsevier Ltd.
引用
收藏
页码:4474 / 4489
页数:16
相关论文
共 118 条
[31]   The exploration of macrocycles for drug discovery - an underexploited structural class [J].
Driggers, Edward M. ;
Hale, Stephen P. ;
Lee, Jinbo ;
Terrett, Nicholas K. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) :608-624
[32]   Site-directed ligand discovery [J].
Erlanson, DA ;
Braisted, AC ;
Raphael, DR ;
Randal, M ;
Stroud, RM ;
Gordon, EM ;
Wells, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9367-9372
[33]   Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].
Flaherty, Keith T. ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
O'Dwyer, Peter J. ;
Lee, Richard J. ;
Grippo, Joseph F. ;
Nolop, Keith ;
Chapman, Paul B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819
[34]   Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator [J].
Frederickson, Martyn ;
Callaghan, Owen ;
Chessari, Gianni ;
Congreve, Miles ;
Cowan, Suzanna R. ;
Matthews, Julia E. ;
McMenamin, Rachel ;
Smith, Donna-Michelle ;
Vinkovic, Mladen ;
Wallis, Nicola G. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (02) :183-186
[35]   Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules [J].
Galloway, Warren R. J. D. ;
Isidro-Llobet, Albert ;
Spring, David R. .
NATURE COMMUNICATIONS, 2010, 1
[36]   The discovery of antibacterial agents using diversity-oriented synthesis [J].
Galloway, Warren R. J. D. ;
Bender, Andreas ;
Welch, Martin ;
Spring, David R. .
CHEMICAL COMMUNICATIONS, 2009, (18) :2446-2462
[37]   Dynamic Combinatorial Selection of Molecules Capable of Inhibiting the (CUG) Repeat RNA-MBNL1 Interaction In Vitro: Discovery of Lead Compounds Targeting Myotonic Dystrophy (DM1) [J].
Gareiss, Peter C. ;
Sobczak, Krzysztof ;
McNaughton, Brian R. ;
Palde, Prakash B. ;
Thornton, Charles A. ;
Miller, Benjamin L. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (48) :16254-16261
[38]   Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays [J].
Haggarty, SJ ;
Koeller, KM ;
Wong, JC ;
Butcher, RA ;
Schreiber, SL .
CHEMISTRY & BIOLOGY, 2003, 10 (05) :383-396
[39]   Fragment-based drug design: How big is too big? [J].
Hajduk, Philip J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :6972-6976
[40]   Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer [J].
Hann, Christine L. ;
Daniel, Vincent C. ;
Sugar, Elizabeth A. ;
Dobromilskaya, Irina ;
Murphy, Sara C. ;
Cope, Leslie ;
Lin, Xue ;
Hierman, Jared S. ;
Wilburn, Daniel L. ;
Watkins, D. Neil ;
Rudin, Charles M. .
CANCER RESEARCH, 2008, 68 (07) :2321-2328